A Randomized, Open-label, Single Dose, Two-treatment, Two-period, Two-sequence Crossover Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine After Oral Administration in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 31 May 2017
Price : $35 *
At a glance
- Drugs Levamlodipine/telmisartan (Primary) ; Atorvastatin
- Indications Essential hypertension; Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 19 Aug 2013 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea record: KCT0000811)
- 19 Aug 2013 Planned End Date changed from 1 Jul 2013 to 12 Jul 2013 as reported by Korean Clinical Trials Register record.
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.